In Vitro Fertilization (IVF) Asia-Pacific Market to Reach $3.5 Billion in Revenues by 2020

1
In Vitro Fertilization (IVF) Asia-Pacific Market
- Opportunities and Forecasts, 2014 - 2020
Published on 01 March, 2016 Number of pages
124 Single User Price 4515
The research methodology used to estimate and
forecast In Vitro Fertilization (IVF)
Asia-Pacific Market begins with capturing data on
key vendor revenue through the secondary research.
2
Summary of the Report The In Vitro
Fertilization or fertilization is a process in
which an egg is fertilized in the glass or test
tube out of the body in a controlled environment
and after successful fertilization it is
implanted into the womans body. Due to the rise
in infertility and late pregnancy there is a rise
in the IVF process in many countries across the
Asia Pacific region. There is high scope for the
growth in the In Vitro Fertilization (IVF)
Asia-Pacific Market through 2020. 
Click Here To Check Complete Report
3
Topics Covered in this report Scope and
Regional Forecast of the In Vitro Fertilization
(IVF) Asia-Pacific Market   In the In Vitro
Fertilization (IVF) Asia-Pacific Market, major
driving countries are China and India due to the
high population of the region. IVF in India is
growing at a fast rate due to the rise in
standard of living and availability of medical
facilities for infertility, artificial
insemination and test tube baby in the
region.   The driving factors of the In Vitro
Fertilization (IVF) Asia-Pacific Market are rise
in infertility rate due to rise in stress levels,
change in life style and fertility related
diseases. Globally, around 15 of the couples
face infertility issues in which males contribute
to 20-30 of the overall cases.          
4
The major limiting factors of the In Vitro
Fertilization (IVF) Asia-Pacific Market are the
cost involved and lower success rates in the
treatment. Patients may not conceive in the first
cycle of embryo transfer procedure. Patients have
to undergo many cycles to achieve pregnancy, and
this adds to the overall cost.   Segmentation and
Key Players of the In Vitro Fertilization (IVF)
Asia-Pacific Market   The In Vitro
Fertilization (IVF) Asia-Pacific Market is
segmented into various categories by end user, by
cycle type and by geography.   By end user
Hospitals, Surgical centers and Clinical research
institutes   By cycle type Fresh cycle
(non-donor), Thawed IVF cycle (non-donor) and
Donor egg IVF cycles
Download Sample Brochure
5

• The key players in the In Vitro Fertilization
  (IVF) Asia-Pacific Market are as follows
• Genea Biomedx
• Thermo Fisher Scientific Inc.
• Virtus Health
• Monash IVF
• City Fertility
•  
• The In Vitro Fertilization (IVF) Asia-Pacific
  Market is a rapidly growing market with high
  applications in medical sector for infertility
  cases. IVF success rates are high and IVF
  pregnancy is expected to grow in demand with a
  steady pace despite the cost of the IVF procedure
  in the medical sector across the globe through
  2020.

Inquiry Before Buying
6
In Vitro Fertilization (IVF) Asia-Pacific Market
- Opportunities and Forecasts, 2014 - 2020
A detailed qualitative analysis of the factors
responsible for driving and restraining growth of
the In Vitro Fertilization (IVF) Asia-Pacific
Market and future opportunities are provided in
the report.
Contact 1-302-261-5343 sales_at_marketintelreports.c
om www.marketintelreports.com
Click here to order a copy of In Vitro
Fertilization (IVF) Asia-Pacific 2014-2020 Market
Research Report